• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Solventum Corporation Common Stock (NY:SOLV)

    87.29 +0.88 (+1.02%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Solventum Corporation Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
    From Wall Street Investor
    Via GlobeNewswire
    News headline image
    3 Overrated Stocks We Approach with Caution
    The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
    Via StockStory
    News headline image
    Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
    Looking back on surgical equipment & consumables - diversified stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including CONMED (NY... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    2 Profitable Stocks for Long-Term Investors and 1 We Question
    Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
    Via StockStory
    Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds ↗
    Via Chartmill
    News headline image
    Due Diligence Check: Do These "Blue Chips" Still Earn the Title? ↗
    "Blue chip" gets applied to a company once and tends to stick, regardless of what the balance sheet does afterward. The label describes reputation, not cur 
    Via Talk Markets
    News headline image
    Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses
    As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    3 S&P 500 Stocks with Open Questions
    The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
    Via StockStory
    Topics Stocks
    News headline image
    2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
    Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
    Via StockStory
    Topics Energy
    News headline image
    3 Value Stocks with Open Questions
    Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
    Via StockStory
    News headline image
    3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
    Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due t... 
    Via StockStory
    Topics Stocks
    News headline image
    1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
    Via StockStory
    News headline image
    Solventum (SOLV) Q2 2026 Earnings Call Transcript ↗
    CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth. 
    Via The Motley Fool
    Topics Earnings World Trade
    News headline image
    The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
    News Provided by USA News Group on behalf of Conexeu Sciences Inc. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
    The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Solventum Q2 Earnings Call Highlights ↗
    Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff... 
    Via MarketBeat
    Topics ETFs Earnings World Trade
    News headline image
    SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
    Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.... 
    Via StockStory
    News headline image
    Solventum Nears Inflection Point As It Begins to Unlock Value ↗
    Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers. 
    Via MarketBeat
    Topics Initial Public Offering
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026
    Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to ... 
    Via StockStory
    Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    What To Expect From Solventum’s (SOLV) Q2 Earnings
    Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results this Wednesday after market hours. Here’s what you need to know. Solventum beat... 
    Via StockStory
    News headline image
    3 Hyped Up Stocks That Fall Short
    Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements... 
    Via StockStory
    Exploring the top movers within the S&P500 index during today's session. ↗
    Via Chartmill
    Tuesday's session: top gainers and losers in the S&P500 index ↗
    Via Chartmill
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    3 Reasons SOLV is Risky and 1 Stock to Buy Instead
    Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P ... 
    Via StockStory
    Topics Stocks
    News headline image
    2 S&P 500 Stocks to Own for Decades and 1 We Question
    The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
    Via StockStory
    Topics Stocks
    News headline image
    3 Mid-Cap Stocks We Steer Clear Of
    Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
    Via StockStory
    News headline image
    3 Healthcare Stocks with Questionable Fundamentals
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.